@Tooheys8
Happy to be corrected, I suspect it is basically because it provides 'immediate access' to a much larger patient 'data-set' to move the 'breadth' of the testing/assessments forward far more quickly than waiting (and paying) for access to 'fresh' new-samples as they become available...
Reading between the lines, it seems exosomes have a 'shelf-life' as such, so will basically required UQ & IIQ to 'revert' to basically acquiring access to 'fresh samples' on an ongoing basis to move the test forward (get 'statistical runs' on the board with a significant sample size), collate and then, present to industry, hence the H2FY24 delay-statement...
ML
- Forums
- ASX - By Stock
- IIQ
- Ann: EXO-OC PROGRAM COMPLETES SERUM EQUIVALENCE STUDY
Ann: EXO-OC PROGRAM COMPLETES SERUM EQUIVALENCE STUDY, page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.5¢ |
Change
-0.015(3.13%) |
Mkt cap ! $42.78M |
Open | High | Low | Value | Volume |
48.0¢ | 48.0¢ | 46.5¢ | $61.33K | 130.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 123511 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.5¢ | 2197 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 123511 | 0.465 |
1 | 6000 | 0.460 |
3 | 30747 | 0.450 |
1 | 833 | 0.445 |
1 | 5000 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.475 | 2197 | 1 |
0.480 | 5000 | 1 |
0.485 | 11678 | 2 |
0.490 | 8024 | 2 |
0.495 | 10000 | 1 |
Last trade - 13.26pm 30/05/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online